• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Scinai Immunotherapeutics Ltd (SCNI)

American Depository Receipt
Sell: $2.03|Buy: $2.06|Change: 0.01 (-0.60%)

This share can be held in a Dealing account

Company profile

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

Address

14 Einstein Street
PO Box 4143
Ness Ziona
ISR
74036

Telephone

+972 89302529

Website

https://www.scinai.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Scinai Immunotherapeutics Ltd Second Quarter Earnings Results for 20272027-08-24T00:00:00
Scinai Immunotherapeutics Ltd First Quarter Earnings Results for 20272027-06-10T00:00:00
Scinai Immunotherapeutics Ltd Fourth Quarter Earnings Results for 20262027-04-01T00:00:00
Scinai Immunotherapeutics Ltd Annual Report for 20262027-04-01T00:00:00
Scinai Immunotherapeutics Ltd Annual General Meeting for 20262026-12-22T11:00:00
Scinai Immunotherapeutics Ltd Third Quarter Earnings Results for 20262026-12-02T00:00:00

Previous key dates

NameKey Date
Scinai Immunotherapeutics Ltd Second Quarter Earnings Results for 20262026-08-24T00:00:00
Scinai Immunotherapeutics Ltd First Quarter Earnings Results for 20262026-06-10T00:00:00
Scinai Immunotherapeutics Ltd Fourth Quarter Earnings Results for 20252026-04-01T00:00:00
Scinai Immunotherapeutics Ltd Annual Report for 20252026-04-01T00:00:00
Scinai Immunotherapeutics Ltd Annual General Meeting for 20252025-12-22T11:00:00
Scinai Immunotherapeutics Ltd Third Quarter Earnings Results for 20252025-12-02T00:00:00
Scinai Immunotherapeutics Ltd Second Quarter Earnings Results for 20252025-09-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.